
Suven Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 29, 2023, titled "Advent International announces the completion of the acquisition of Suven Pharma".
Filed with NSE ·

Suven Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 29, 2023, titled "Advent International announces the completion of the acquisition of Suven Pharma".
6ix hasn’t read this filing yet.
Cohance Lifesciences Ltd on 6ix
Follow Cohance Lifesciences into a list and get an email when it puts out news.
Follow Cohance Lifesciences